Why Patheon N.V. (PTHN) jump 33% on 05/15/17?

Patheon N.V. (PTHN) jump 33% as a result of Bullish news signal:

Thermo Fisher Scientific said Monday it will pay $5.2 billion to acquire North Carolina drug ingredients maker Patheon NV, allowing the Waltham scientific instruments giant to offer a broader array of services to its pharma and biotech customers. Thermo Fisher (TMO) said it would pay $35 per share for Patheon (PTHN), a 35 percent premium over the firm’s closing share price Friday. Patheon is headquartered in Durham, North Carolina, and has around 9,000 employees worldwide

As a contract development and manufacturing organization, or CDMO, Patheon makes ingredients for small molecule drugs and biologics, and also helps drugmakers advance treatments through clinical trials. Thermo Fisher, which makes a variety of scientific tools and tests, said the deal would allow it to tap into the CDMO market, which has grown as drugmakers look for ways to more quickly — and cheaply — get products onto the market. The deal is expected to close by year-end. Thermo Fisher has committed debt financing from Goldman Sachs and expects to finance the deal with about $5.2 billion of debt and $2 billion of equity

Explanation:

Why Bullish? the deal interest is one of the best events for a stock rally, therefore, will impact the stock in today trade and also up to 14 days, which will impact the stock in today trade and in the up to 14 days. The stock has been impacted by the bullish news and jumped by 33%. It is very common that these type of news (i.e. acquired company announcement) will impact the stock in a bullish manner. therefore, we provide this stock a short-term bullish signal